Last updated on September 2018

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies


Brief description of study

The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02390 in participants with select advanced malignancies.

Clinical Study Identifier: NCT03652077

Contact Investigators or Research Sites near you

Start Over

Incyte Corporation Call Center (US)

The Angeles Clinical and Research Institute
Los Angeles, CA United States
  Connect »

Incyte Corporation Call Center (US)

University of Mississippi
Jackson, MS United States
  Connect »

Incyte Corporation Call Center (US)

Carolina BioOncology
Huntsville, NC United States
  Connect »